Boston Scientific Deferred and prepaid income taxes decreased by 1495.5% to -$351.00M in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 956.1%, from $41.00M to -$351.00M.
Positive values suggest tax payments are deferred to future periods, while negative values indicate cash outflows for taxes exceeding current period expense.
This metric reflects the timing differences between when income tax expense is recognized in the financial statements an...
Common in large multinational corporations with complex global tax structures.
operating_cash_flow_impact_of_deferred_income_tax_expens_db5917| Q2 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q1 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | -$87.00M | -$75.00M | -$75.00M | -$18.00M | $19.00M | -$64.00M | -$29.00M | $31.00M | -$80.00M | $41.00M | -$90.00M | $69.00M | -$22.00M | -$351.00M |
| QoQ Change | — | +13.8% | +0.0% | +76.0% | +205.6% | -436.8% | +54.7% | +206.9% | -358.1% | +151.3% | -319.5% | +176.7% | -131.9% | <-999% |
| YoY Change | — | — | — | +79.3% | +125.3% | -255.6% | — | +63.2% | — | +32.3% | — | — | +72.5% | -956.1% |